Search Results - "Romero Guillena, S. L."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions and emergency room visits. 66 months of follow-up by Romero Guillena, S. L., Plasencia Garcia de Diego, B. O., Gomez Gonzalez, J., Gotor Sánchez-Luengo, F.

    Published in European psychiatry (01-03-2023)
    “…IntroductionPaliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and…”
    Get full text
    Journal Article
  2. 2

    PALIPERIDONE PALMITATE 6-MONTH FORMULATION FOR THE TREATMENT OF SCHIZOPHRENIA: A 4-MONTH FOLLOW-UP STUDY by Romero Guillena, S L, G Rodriguez Menendez, Florido Puerto, A I, Fernández Flores, A S

    Published in European psychiatry (01-03-2023)
    “…IntroductionRelapse prevention is critical because psychopathology and functionality can worsen in patients with schizophrenia because the repeated episodes…”
    Get full text
    Journal Article
  3. 3

    Paliperidone palmitate 6-month formulation for the treatment of schizophrenia: a 14-month follow-up study by Romero Guillena, S L, H Marín Mateos, G Rodriguez Menendez

    Published in European psychiatry (01-08-2024)
    “…IntroductionRelapse prevention is critical because psychopathology and functionality can worsen in patients with schizophrenia because the repeated episodes…”
    Get full text
    Journal Article
  4. 4

    Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen. A 24 months follow-up and mirror image study by Romero Guillena, S L, F Gotor Sanchez-Luengo, B O Plasencia Garcia de Diego

    Published in European psychiatry (01-08-2024)
    “…IntroductionRelapse prevention is crucial in patients with schizophrenia, as repeated episodes can worsen psychopathology and functionality. There is strong…”
    Get full text
    Journal Article
  5. 5

    Comparison of prevalence, clinical evolution, and vaccination rate against covid 19 in a population of patients diagnosed with dual depression and non-dual depression by Romero Guillena, S.L., Dopico Cervera, A.M., Pérez Romero, A.

    Published in European psychiatry (01-06-2022)
    “…IntroductionSince the beginning of the pandemic, 4,745,519 cases, 396,878 hospitalizations and 82,884 deaths with COVID-19 have been reported in Spain. As of…”
    Get full text
    Journal Article
  6. 6

    Alternative initiation regimen of paliperidone palmitate long-acting injectable by Menendez Gil, I.E., Romero Guillena, S.L., Plasencia Garcia De Diego, B.O.

    Published in European psychiatry (01-06-2022)
    “…IntroductionLong-acting injectable antipsychotics (LAIs) hold an important place in the treatment of psychosis. Knowledge of the best way to administer LAIs is…”
    Get full text
    Journal Article
  7. 7

    Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions. 60 months of follow-up by Romero Guillena, S.L., Plasencia Garcia De Diego, B.O., Gotor Sanchez-Luengo, F.

    Published in European psychiatry (01-06-2022)
    “…IntroductionPaliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and…”
    Get full text
    Journal Article
  8. 8

    Prevalence and covid 19 vaccination rate in a population of patients with schizophrenia and a substance use disorder by Romero Guillena, S.L., De Burgos Berdud, I., Gálvez Medina, R., Serrano Rodriguez, E.

    Published in European psychiatry (01-06-2022)
    “…IntroductionAs of August 27th, 2021, the diagnosed cases of COVID 19 in Spain are 4 758 003 with a prevalence of 10.03%. 68.4% of the Spanish population is…”
    Get full text
    Journal Article
  9. 9

    Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen by Romero Guillena, S.L., Plasencia Garcia De Diego, B.O., Gotor Sanchez-Luengo, F., Gómez González, J.

    Published in European psychiatry (01-06-2022)
    “…IntroductionAripiprazole once-monthly is a long-acting intramuscular injectable formulation of aripiprazole. The starting dose can be administered by following…”
    Get full text
    Journal Article
  10. 10

    Barriers and facilitators associated with pharmacological treatment in bipolar disorder patients by Partera, J.Á. Alcalá, Navas, A. Fontalba, Morales, M. Company, Guillena, S.L. Romero, Higueras, T. Gutiérrez, Cortés, F. Calera, Forés, S. Vicent, Rojas, L. Gutiérrez

    Published in European psychiatry (01-04-2021)
    “…IntroductionThe main factors that are involved in a correct adherence to the therapeutic recommendations in Bipolar Disorder includes aspects related to age,…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Psicopatía, violencia y criminalidad: un análisis psicológico-forense, psiquiátrico-legal y criminológico (Parte II) by Pozueco Romero, J.M., Romero Guillena, S.L., Casas Barquero, N.

    Published in Cuadernos de medicina forense (01-12-2011)
    “…La Jurisprudencia española se encuentra frecuentemente ante dictámenes periciales en los que aparecen términos como psicópata, trastorno antisocial de la…”
    Get full text
    Journal Article
  13. 13

    Psicopatía, violencia y criminalidad: un análisis psicológico-forense, psiquiátrico-legal y criminológico (Parte I) by Pozueco Romero, J.M., Romero Guillena, S.L., Casas Barquero, N.

    Published in Cuadernos de medicina forense (01-09-2011)
    “…Tras más de 200 años de historia, el concepto de "psicopatía" ha venido experimentando una auténtica y variopinta metamorfosis terminológica. Exceptuando…”
    Get full text
    Journal Article